BioSpace News Archive

Exactech Announces Successful First Revision Knee Replacement Surgery With Truliant® Instrumentation

Orthopaedic surgeons will have a chance to experience the Truliant primary and revision systems through live mechanical demonstrations Nov. 2-5 at the American Association of Hip and Knee Surgeons (AAHKS) Annual Meeting, Booth #908 in Dallas, Texas.

November 1, 2017
·
2 min read
Bio NC

CALQUENCE (Acalabrutinib) Approved for Previously-Treated Mantle Cell Lymphoma, Available for Order at Biologics, Inc.

CALQUENCE is a highly selective orally available potent inhibitor of Bruton’s tyrosine kinase (BTK).

November 1, 2017
·
4 min read
Business

DiaMedica Announces Dr. Robert Stanton as Scientific Advisor for Upcoming Chronic Kidney Disease Trials

Stanton will serve on DiaMedica’s Kidney Scientific Advisory Board.

November 1, 2017
·
3 min read
Business

Aduro Biotech Reports Third Quarter 2017 Financial Results

Net loss for the third quarter of 2017 was $24.5 million, or $0.33 per share.

November 1, 2017
·
9 min read
Business

Prothena to Report Third Quarter 2017 Financial Results on November 7

Consistent with past practice, the Company will not be conducting a conference call in conjunction with this financial results release on November 7.

November 1, 2017
·
1 min read
Business

TRACON to Report Third Quarter Company Highlights and Financial Results on November 7, 2017

In addition, management will host a conference call to provide an update on corporate activities and discuss the quarterly financial results.

November 1, 2017
·
1 min read
Late-Breaking REDUCE Trial Data Demonstrate Non-Inferiority of 3 vs 12 Months Dual Antiplatelet Therapy in Acute Coronary Syndrome Patients Treated With OrbusNeich’s COMBO Stent

The trial found no difference in the primary endpoint between three and 12 months DAPTin the intent to treat (ITT) population.

November 1, 2017
·
5 min read
Deals

Sterigenics International Acquires Toxikon’s European Laboratory Business

Terms of the deal were not disclosed.

November 1, 2017
·
4 min read
Business

Novo Nordisk Increased Reported Operating Profit by 5% in the First Nine Months of 2017

Reported sales increased by 2% to DKK 83.7 billion (3% in local currencies).

November 1, 2017
·
3 min read
BioCapital

Integrated Biotherapeutics Partners With CARB-X the First Toxoid Based Multivalent Vaccine for Methicillin-Resistant Staphylococcus Aureus

Integrated BioTherapeutics announced today that is has been awarded up to $168,000, with the possibility of up to $8.3M more based on the achievement of milestones, to develop the first entirely toxoid-based multivalent vaccine for the prevention of MRSA.

November 1, 2017
·
3 min read